JCP
LLY icon

Jabre Capital Partners’s Eli Lilly LLY Stock Holding History

Jabre Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-200,000
Closed -$10.2M – 134
2013
Q4 		$10.2M Buy
200,000
+65,000
+48% +$3.25M 0.78% 36
2013
Q3 		$6.79M Buy
+135,000
New +$7.07M 0.76% 45

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jabre Capital Partners's LLY Position: Q1 2014 in Review

Jabre Capital Partners sold out of Eli Lilly (LLY) in Q1 2014, closing a stake of 200,000 shares — an estimated $10.2M sold.

Jabre Capital Partners first reported a position in LLY in Q3 2013 and held it in 2 quarters. The position peaked at $10.2M in Q4 2013. 1,025 funds tracked by Wall St. Rank hold LLY as of Q1 2014.

  • Jabre Capital Partners reported no remaining Eli Lilly position as of Q1 2014 after selling out during the quarter.
  • Jabre Capital Partners sold 200,000 Eli Lilly shares in Q1 2014, an estimated $10.2M.
  • Jabre Capital Partners first reported a position in Eli Lilly in Q3 2013 and held it in 2 quarters.
  • Jabre Capital Partners's Eli Lilly position peaked at $10.2M in Q4 2013.
  • 1,025 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2014.

Based on Jabre Capital Partners's 13F filing for Q1 2014, filed 15 May 2014.